Skip to main content
Clinical Trials/CTRI/2017/03/008062
CTRI/2017/03/008062
Completed
未知

Evaluation of the prescription pattern of drugs and adherence of physicians to NeuPSIG guidelines in treatment of cancer related neuropathic pain.

Dr Vishal Singh0 sites291 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Vishal Singh
Enrollment
291
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 30, 2021
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Dr Vishal Singh

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients of either gender and age above of 18 years and below 80 years experiencing from neuropathic pain due to any cancer.
  • 2\. Patients diagnosed by treating physicians as having neuropathic pain using the screening tool DN4 Neuropathic pain diagnostic questionnaire with score \>\= 4
  • 3\. Patients willing to give voluntary informed consent.

Exclusion Criteria

  • 1\. Patients with established diagnosis of neurogenic pain associated with localized peripheral neuropathies (e.g. Post herpetic neuralgia, Diabetic neuropathy, Post\- surgical/traumatic neuropathic pain.)
  • 2\. Patients unable to comprehend the patient information sheet.
  • 3\. Patients diagnosed with fibromyalgia.
  • 4\. Any other medical condition, which in the opinion of the investigator precludes the
  • inclusion of the participant.

Outcomes

Primary Outcomes

Not specified

Similar Trials